Targeted and controlled anticancer drug delivery and release with magnetoelectric nanoparticles

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Rodzinski, Alexandra ^a   Guduru, Rakesh ^a   Liang, Ping ^b,c   Hadjikhani, Ali ^d   Stewart, Tiffanie ^a   Stimphil, Emmanuel ^d   Runowicz, Carolyn ^a   Cote, Richard ^e,f   Altman, Norman ^e   Datar, Ram ^e,f   Khizroev, Sakhrat ^a,d  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^b University of California Riverside   (United States)

^c Cellular Nanomed Inc   (United States)

^d Florida International University   (United States)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIBODY CONJUGATE; ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN; MAGNETITE NANOPARTICLE; PACLITAXEL;

ANIMAL; CHEMISTRY; DEVICES; DRUG DELIVERY SYSTEM; DRUG SCREENING; FEMALE; HUMAN; MAGNET; MAGNETIC FIELD; METABOLISM; MOUSE; NUDE MOUSE; OVARIAN NEOPLASMS; PARTICLE SIZE; PATHOLOGY; PROCEDURES; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME; TUMOR CELL LINE; ULTRASTRUCTURE;

ANIMALS; ANTIBODIES; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; IMMUNOCONJUGATES; INJECTIONS, SUBCUTANEOUS; MAGNETIC FIELDS; MAGNETITE NANOPARTICLES; MAGNETS; MICE; MICE, NUDE; OVARIAN NEOPLASMS; PACLITAXEL; PARTICLE SIZE; RECEPTOR, ERBB-2; TREATMENT OUTCOME; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84959480192     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep20867     Document Type: Article

References (60)

1. Kantoff, P. W. et al. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. New England Journal of Medicine, 363(5), 411-422 (2010).
2. Lee, D. W., Barret, D. M., Mackall, C., Orentas, R., Grupp, S. A. The future is now: chimeric antigen receptors as new targeted therapies for childhood cancer. Clin Cancer Res. 18(10), 2780-2790 (2012).
3. Vasir, J. K. Labhasetwar, Targeted drug delivery in cancer therapy. Technology in cancer research & treatment 4, 3636 (2005).
4. Wang, A. Z., Langer, R., Farokhzad, O. C. Nanoparticle delivery of cancer drugs. Annual Review Medicine 63, 185-198 (2012).
5. Brigger, I., Dubernet, C., Couvreur, P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Delivery Reviews 64, 24-36 (2012).
6. Pridgen, E. M., Langer, R., Farokhzad, O. C. Biodegradale, polymeric nanoparticle delivery systems for cancer therapy. Nanomedicine 2, 669-680 (2007).
7. Tong, R., Hemmati, H. D., Langer, R., Kohane, D. S. Photoswitchable nanoparticles for triggered tissue penetration and drug delivery. Journal of the American Chemical Society 134, 8848 (2012).
8. Batrakova, E. V., Gendelman, H. E., Kabanov, A. V. Cell-mediated drugs delivery. Expert Opin Deliv. 8(4), 415-433 (2011).
9. Cheong, I. et al. A bacterial protein enhances the release and efficacy of liposomal cancer drugs. Science 314, 1308 (2006).
10. Derfus, A. M. et al. Remotely triggered release from magnetic nanoparticles. Adv. Mater. 19, 3932-6 (2007).
11. Timko, B. P., Dvir, T., Kohane, D. Remotely triggerabe drug delivery systems. Adv. Mater. 22, 4925-43 (2010).
12. Senyei, A., Widder, K., Czerlinski, C. Magnetic guidance of drug carrying microspheres. J Appl Phys. 49, 3578-83 (1978).
13. McBain, S. C., Yiu, H. P. Dobson. Magnetic nanoparticles for gene and drug delivery. Int J Nanomedicine. 3(2), 169-180 (2008).
14. Torchilin, V. P. Recent advances with liposomes as pharmaceutical carriers. Nature Reviews 4, 145-60 (2005).
15. Arruebo, M., Fernandez-Pacheco, R., Ibarra, M. R. Santamaria. Magnetic nanoparticles for drug delivery. Nano Today 2(3), 22-32 (2007).
16. Hoare, T. et al. A magnetically triggered composite membrane for on-demand drug delivery. Nano letters 9, 3651 (2009).
17. Brasseur, F. et al. Actinomycin D absorbed on polymethylcyanoacrylate nanoparticles: increased efficiency against an experimental tumor. Eur. J. Cancer. 16(11), 1441-1445 (1980)
18. Maeda, H. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv. Enzyme Regul. 41, 189-207 (2001).
19. Prabhakar, U. et al. nced permeaility and retention effect for nanomedicine drug delivery in oncology. Cancer Res. 73(8), 2412-7 (2013).
20. Oldham, R. K., Dillman, R. O. Monoclonal antibodies in cancer therapy: 25 years of progress. Journal of Clinical Oncology 26, 1774 (2008).
21. Tai, W., Mohato, R., Cheng, K. T. The role of HER2 in cancer therapy and targeted drug delivery. J. Control Release. 146(3), 246-275 (2010).
22. Li, X., Zhao, Q., L. Qiu & L. Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy. J. Control Release 171(2), 152-162 (2013).
23. Wei, X., Chen, X., Ying, M., Lu. W. Brain tumor-targeted drug delivery strategies. Acta Pharmaceutica Sinica B. 4(3), 193-201 (2014).
24. Firer, M., Gellerman, G. J. Targeted drug delivery for cancer therapy: the other side of antibodies. J. Hematology & Oncology 5, 70 (2012).
25. Barua, S. et al. Particle shape enhances specificity of antibody-displaying nanoparticles. Proceedings of the National Academy of Sciences 110, 3270 (2013).
26. Danhier, F., Feron, O., Preat, V. To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J. Control. Release 148(2), 135-146 (2010).
27. Zhang, W., Gilstrap, K., Wu, L. et al. Synthesis and characerization of thermally responsive Pluronic F127-chitosan nanocapsules for controlled release and intracellular delivery of small molecules. ACS Nano 4(11), 6747-6759 (2010).
28. Wu, G., Mikhailovsky, A., Khant, H. A., Fu, C., Chiu, W., Zasadzinski, J. A. Remotely triggered liposomal release by near-infrared light absorption via hollow gold nanoshells. J. Am. Chem. Soc. 130(26), 8175-8177 (2008).
29. Cochran, M. C. et al. Disposition of ultrasound sensitive polymeric drug carrier in a rat hepatocellular carcinoma model. Acad. Radiol. 18(11), 1341-1348 (2011).
30. Lin, C. Y., Li, J. R., Tseng, H. C., Wu, M. F., Lin, W. L. Enhancement of focused ultrasound with microbubbles on the treatments of anticancer nanodrug in mouse models. Nanomedicine 8(6), 900-907 (2012).
31. Lim, E. K., Huh, Y. M., Yang, J., Lee, K., Suh, J. S., Haam, S. pH-triggered drug-releasing magnetic nanoparticles for cancer therapy guided by molecular imaging by MRI. Adv. Mater. 23(21), 2436-2442 (2011).
32. Putnam, D., Kopecek, Enantioselective release of 5-Fluorouracil from N-(2-Hydroxypropyl)methacrylamide-Based Copolymers via Lysosomal Enzymes. Bioconjug. Chem. 6(4), 483-492 (1995).
33. Kopecek, Polymer conjugates with anticancer activity. Biomaterials 5(1), 19-25 (1984).
34. Wong, C. et al. Multistage nanoparticle delivery system for deep penetration into tumor tissue. Proc. Natl. Acad. Sci. USA 108(6), 2426-2431 (2011).
35. Brannon-Peppas, L., Blanchette, J. O. Nanoparticle and targeted systems for cancer therapy. Advanced drug delivery reviews 56, 1649 (2004).
36. Nair, M. et al. Externally controlled on-demand release of anti-HIV drug using magneto-electric nanoparticles as carriers. Nature communications 4, 1707 (2013).
37. Yue, K. et al. Magneto-Electric Nano-Particles for Non-Invasive Brain Stimulation. PloS one 7, e44040 (2012).
38. Guduru, R. et al. Magnetoelectric "spin" on stimulating the brain. Nanomedicine 10(13), 1-11 (2015).
39. Guduru, R. et al. Magnetoelectric nanoparticles to enable field-controlled high-specificity drug delivery to eradiate ovarian cancer cells. Scientific Reports 3, 2953 (2013).
40. Guduru, R., Khizroev, S. Magnetic-field-controlled release of paclitaxel drug from functionalized magneto-electric nanoparticles. Particle and Particle Systems Characterization 31(5), 605-611 (2014).
41. Binggeli, R., Cameron, I. L. Canc. Cellular potentials of normal and cancerous fibroblasts and hepatocytes. Cancer research 40, 1830 (1980).
42. Cahill, K. M. Molecular electroporation and the transduction of oligoarginines. Physical Biology 7, 016001 (2010).
43. Redmann, K., Muller, V., Tanneberger, S., Kalkoff, W. The membrane potential of primary ovarian tumor cells in vitro and its dependence on the cell cycle. ABMGA J 28(4), 565-713 (1972).
44. Armstrong, D. K. et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. New England Journal of Medicine 354, 34 (2006).
45. Kim, D. W. et al. Multicener phase II trial of Genexol-PM, a novel Cremorphor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer. Ann. Oncol. 18, 2009-2014 (2008).
46. Corral-Flores, V., Bueno-Baques, D., Ziolo, R. Synthesis and characterization of novel CoFe2O4-BaTiO3 multiferroic core-shelltype nanostructures. Acta Materialia 58, 764 (2010).
47. Xie, X., Ma, F., Liu, Y., Li, J. Multiferroic CoFe2O4-Pb (Zr0. 52Ti0. 48) O3 core-shell nanofibers and their magnetoelectric coupling. Nanoscale 3, 3152 (2011).
48. Kimura, T. et al. Magnetic control of ferroelectric polarization. Nature 426, 55 (2003).
49. Eerenstein, W., Mathur, N., Scott, J. F. Multiferroic and magnetoelectric materials. Nature 442, 759 (2006).
50. Valencia, S. et al. Interface-induced room-temperature multiferroicity in BaTiO3. Nature Materials 10, 753 (2011).
51. Veronese, F. M., Pasut, G. PEGylation, successful approach to drug delivery. Drug Discovery Today 10(21), 1451-1458 (2005).
52. Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., Preat, V. PLGA-based nanoparticles: an overview of biomedical applications. J. Controlled Resease 161(2), 505-522 (2012).
53. Weizenecker, J., Gleich, B., Rahmer, J., Dahnke, H., Borgert, J. Three-dimensional real-time in vivo magnetic particle imaging. Phys. Med. Biol. 54, L1 (2009).
54. Kim, D. K., Zhang, Y., Kehr, K., Klason, T., Bjelke, B., Muhammed, M. Characterization and MRI study of surfactant-coated superparamagnetic nanoparticles administrated into the rat brain. J Mag Mag Mat. 225, 256-261 (2001).
55. Kunjachan, S. et al. Passive versus active tumor targeting using RGD-and NGR-modified polymeric nanomedicines. Nano Lett. 14, 972-981 (2014).
56. Fullstone, G., Wood, J., Holcombe, M., Battaglia, G. Modeling the transport of nanoparticles under blood flow using an agentbased approach. Sci. Rep. 5, 10649 (2014).
57. Shah, S., Liu, Y., Hu, W., Gao, J. Modeling particle shape-dependent dynamics in nanomedicine. J. Nanosci. Nanotechnol. 11(2), 919-928 (2011).
58. Yang, M., Brackernbury, W. J. Membrane potential and cancer progression. Frontiers in Physiology 4, 185, 1-10 (2013).
59. Hong, J., Bekyarova, E., Liang, P., de Heer, W., Haddon, R. Khizroev, Room-temperature magnetic-order in functionalized graphene. Scientific Reports 2, 624 (2012).
60. Prabha S., Labhasetwar, V. Critical determinants in PLGA/PLA nanoparticlemediated gene expression. Pharm Res. 21(2), 354-364 (2004).